Related Experiment Video
Updated: May 1, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
N(6)-isopentenyladenosine and analogs activate the NRF2-mediated antioxidant response
Alice Dassano1, Mariateresa Mancuso2, Paola Giardullo3
1Department of Predictive and Preventive Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan I-20133, Italy.
Abstract:
N(6)-isopentenyladenosine (i(6)A), a naturally occurring modified nucleoside, inhibits the proliferation of human tumor cell lines in vitro, but its mechanism of action remains unclear. Treatment of MCF7 human breast adenocarcinoma cells with i(6)A or with three synthetic analogs (allyl(6)A, benzyl(6)A, and butyl(6)A) inhibited growth and altered gene expression. About 60% of the genes that were differentially expressed in response to i(6)A treatment were also modulated by the analogs, and pathway enrichment analysis identified the NRF2-mediated oxidative stress response as being significantly modulated by all four compounds. Luciferase reporter gene assays in transfected MCF7 cells confirmed that i(6)A activates the transcription factor NRF2. Assays for cellular production of reactive oxygen species indicated that i(6)A and analogs had antioxidant effects, reducing basal levels and inhibiting the H2O2- or 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced production in MCF7 or dHL-60 (HL-60 cells induced to differentiate along the neutrophilic lineage) cell lines, respectively. In vivo, topical application of i(6)A or benzyl(6)A to mouse ears prior to TPA stimulation lessened the inflammatory response and significantly reduced the number of infiltrating neutrophils. These results suggest that i(6)A and analogs trigger a cellular response against oxidative stress and open the possibility of i(6)A and benzyl(6)A being used as topical anti-inflammatory drugs.
Insights
N(6)-isopentenyladenosine (i(6)A) and its analogs inhibit tumor cell growth by activating the NRF2 pathway, reducing oxidative stress. These compounds also demonstrate topical anti-inflammatory effects by decreasing neutrophil infiltration.
Area of Science:
- Molecular Biology
- Pharmacology
- Cell Biology
Background:
- N(6)-isopentenyladenosine (i(6)A) is a natural nucleoside with known anti-proliferative effects on human tumor cell lines.
- The precise mechanism of action for i(6)A's anti-tumor activity has not been fully elucidated.
Purpose of the Study:
- To investigate the mechanism of action of i(6)A and its synthetic analogs in inhibiting tumor cell proliferation.
- To explore the role of the NRF2 pathway and oxidative stress in i(6)A's effects.
- To evaluate the potential anti-inflammatory properties of i(6)A and its analogs in vivo.
Main Methods:
- Treatment of MCF7 human breast adenocarcinoma cells with i(6)A and synthetic analogs (allyl(6)A, benzyl(6)A, butyl(6)A).
- Gene expression analysis and pathway enrichment analysis (NRF2-mediated oxidative stress response).
- Luciferase reporter gene assays to confirm NRF2 activation.
- Reactive oxygen species (ROS) assays.
- In vivo topical application studies on mouse ears followed by TPA stimulation.
Main Results:
- i(6)A and analogs inhibited MCF7 cell growth and altered gene expression, with significant overlap between compounds.
- The NRF2-mediated oxidative stress response pathway was modulated by all tested compounds.
- i(6)A activated NRF2 transcription and exhibited antioxidant effects, reducing basal and induced ROS production.
- Topical i(6)A and benzyl(6)A reduced TPA-induced inflammation and neutrophil infiltration in mouse ears.
Conclusions:
- i(6)A and its analogs activate the NRF2 pathway, leading to a cellular response against oxidative stress.
- These findings suggest a potential therapeutic application for i(6)A and benzyl(6)A as topical anti-inflammatory agents.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Bioactivation and Tissue Toxicity
Radical Autoxidation
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Role of Reduced Coenzymes NADH and FADH₂

